Bausch & Lomb (TSX:BLCO) FCF Yield % : -0.87 (As of Dec. 12, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Bausch & Lomb FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Bausch & Lomb's Trailing 12-Month Free Cash Flow is C$-79 Mil, and Market Cap is C$9,040 Mil. Therefore, Bausch & Lomb's FCF Yield % for today is -0.87%.

The historical rank and industry rank for Bausch & Lomb's FCF Yield % or its related term are showing as below:

TSX:BLCO' s FCF Yield % Range Over the Past 10 Years
Min: -4.05 Med: -0.36 Max: 9.87
Current: -0.87

During the past 6 years, the highest FCF Yield % of Bausch & Lomb was 9.87%. The lowest was -4.05%. And the median was -0.36%.

TSX:BLCO's FCF Yield % is ranked better than
54.9% of 867 companies
in the Medical Devices & Instruments industry
Industry Median: -2.11 vs TSX:BLCO: -0.87

Bausch & Lomb's FCF Margin % for the quarter that ended in Sep. 2024 was 7.86%.

Bausch & Lomb FCF Yield % Historical Data

The historical data trend for Bausch & Lomb's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch & Lomb FCF Yield % Chart

Bausch & Lomb Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

3.14

-3.34

Bausch & Lomb Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Yield %	Get a 7-Day Free Trial														1.00	-4.65	-1.71	-4.49	5.53

Competitive Comparison of Bausch & Lomb's FCF Yield %

For the Medical Instruments & Supplies subindustry, Bausch & Lomb's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bausch & Lomb's FCF Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bausch & Lomb's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Bausch & Lomb's FCF Yield % falls into.

Bausch & Lomb FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Bausch & Lomb's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-265.637	/	7955.22038
	=	-3.34%

Bausch & Lomb's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	127.332	*	4	/	9203.29278
	=	5.53%

Bausch & Lomb FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Bausch & Lomb FCF Yield % Related Terms

Thank you for viewing the detailed overview of Bausch & Lomb's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch & Lomb Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bausch & Lomb Corp (TSX:BLCO) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

BLCO:USA S2L:Germany

Address

520 Applewood Crescent, Vaughan, ON, CAN, L4K 4B4

Website

https://www.bausch.com

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Executives